RITTER PHARMACEUTICALS INC License Agreements
13 Contracts & Agreements
- License and Sublicense Agreement dated February 15, 2024 between the Company and Pan-RAS Holdings, Inc (Filed With SEC on February 22, 2024)
- First Deed of Variation to License Agreement with UCL Business Limited dated March 30, 2022 (Filed With SEC on May 2, 2023)
- Amendment 1 to the Exclusive License Agreement (RAS), by and between Qualigen, Inc. and University of Louisville Research Foundation, Inc., dated March 16, 2021 (Filed With SEC on May 2, 2023)
- Exclusive License Agreement between the Company and University of Louisville Research Foundation (RAS), Inc., dated as of July 17, 2020 (Filed With SEC on May 2, 2023)
- Amendment 2 to the Exclusive License Agreement (QN-247), by and between Qualigen, Inc. and University of Louisville Research Foundation, Inc., dated January 17, 2023 (Filed With SEC on May 2, 2023)
- Amendment 1 to the Exclusive License Agreement (QN-247), by and between Qualigen, Inc. and University of Louisville Research Foundation, Inc., dated March 16, 2021 (Filed With SEC on May 2, 2023)
- Exclusive License Agreement, by and between the Company and University of Louisville Research Foundation, Inc. dated as of June 9, 2020 (Filed With SEC on August 14, 2020)
- Exclusive License Agreement, by and between Qualigen Therapeutics, Inc. and University of Louisville Research Foundation, Inc. dated as of July 17, 2020 (Filed With SEC on August 4, 2020)
- RITTER PHARMACEUTICALS,INC. AMENDMENT NO. 4 TO RESEARCH AND DEVELOPMENTAGREEMENT & LICENSE (Filed With SEC on March 23, 2015)
- RITTER PHARMACEUTICALS,INC. AMENDMENT NO. 3 TO RESEARCH AND DEVELOPMENTAGREEMENT & LICENSE (Filed With SEC on March 23, 2015)
- RITTER PHARMACEUTICALS,INC. AMENDMENT NO. 2 TO RESEARCH AND DEVELOPMENTAGREEMENT & LICENSE (Filed With SEC on March 23, 2015)
- RITTER PHARMACEUTICALS,INC. AMENDMENT NO. 1 TO RESEARCH AND DEVELOPMENTAGREEMENT & LICENSE (Filed With SEC on March 23, 2015)
- RESEARCH AND DEVELOPMENT AGREEMENT &LICENSE (Filed With SEC on March 23, 2015)
